These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rare germline mutations in African American men diagnosed with early-onset prostate cancer. Beebe-Dimmer JL; Zuhlke KA; Johnson AM; Liesman D; Cooney KA Prostate; 2018 Apr; 78(5):321-326. PubMed ID: 29356034 [TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians. Yadav S; Anbalagan M; Baddoo M; Chellamuthu VK; Mukhopadhyay S; Woods C; Jiang W; Moroz K; Flemington EK; Makridakis N Oncogene; 2020 May; 39(21):4299-4311. PubMed ID: 32300177 [TBL] [Abstract][Full Text] [Related]
5. Commentary on: "Inherited DNA-repair gene mutations in men with metastatic prostate cancer." Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016 Aug 4;375(5):443-53. Lee BH Urol Oncol; 2017 Sep; 35(9):575-576. PubMed ID: 28789927 [TBL] [Abstract][Full Text] [Related]
6. DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men. Plym A; Dióssy M; Szallasi Z; Sartor O; Silberstein J; Powell IJ; Rebbeck TR; Penney KL; Mucci LA; Pomerantz MM; Kibel AS JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35079693 [TBL] [Abstract][Full Text] [Related]
7. DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries. Abdi B; Basset N; Perrot E; Benderra MA; Khalil A; Oudard S; Blanchet P; Brureau L; Coulet F; Cussenot O; Cancel-Tassin G Prostate; 2022 Sep; 82(12):1196-1201. PubMed ID: 35652560 [TBL] [Abstract][Full Text] [Related]
8. Germline and somatic DNA repair gene alterations in prostate cancer. Dall'Era MA; McPherson JD; Gao AC; DeVere White RW; Gregg JP; Lara PN Cancer; 2020 Jul; 126(13):2980-2985. PubMed ID: 32315455 [TBL] [Abstract][Full Text] [Related]
9. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. Pritchard CC; Mateo J; Walsh MF; De Sarkar N; Abida W; Beltran H; Garofalo A; Gulati R; Carreira S; Eeles R; Elemento O; Rubin MA; Robinson D; Lonigro R; Hussain M; Chinnaiyan A; Vinson J; Filipenko J; Garraway L; Taplin ME; AlDubayan S; Han GC; Beightol M; Morrissey C; Nghiem B; Cheng HH; Montgomery B; Walsh T; Casadei S; Berger M; Zhang L; Zehir A; Vijai J; Scher HI; Sawyers C; Schultz N; Kantoff PW; Solit D; Robson M; Van Allen EM; Offit K; de Bono J; Nelson PS N Engl J Med; 2016 Aug; 375(5):443-53. PubMed ID: 27433846 [TBL] [Abstract][Full Text] [Related]
10. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population. Petrovics G; Price DK; Lou H; Chen Y; Garland L; Bass S; Jones K; Kohaar I; Ali A; Ravindranath L; Young D; Cullen J; Dorsey TH; Sesterhenn IA; Brassell SA; Rosner IL; Ross D; Dahut W; Ambs S; Figg WD; Srivastava S; Dean M Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):406-410. PubMed ID: 30542053 [TBL] [Abstract][Full Text] [Related]
11. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698 [TBL] [Abstract][Full Text] [Related]
12. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53. Freedland SJ; Aronson WJ Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer. Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527 [TBL] [Abstract][Full Text] [Related]
14. Bringing Prostate Cancer Germline Genetics into Clinical Practice. Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411 [TBL] [Abstract][Full Text] [Related]
15. Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes. Kohaar I; Zhang X; Tan SH; Nousome D; Babcock K; Ravindranath L; Sukumar G; Mcgrath-Martinez E; Rosenberger J; Alba C; Ali A; Young D; Chen Y; Cullen J; Rosner IL; Sesterhenn IA; Dobi A; Chesnut G; Turner C; Dalgard C; Wilkerson MD; Pollard HB; Srivastava S; Petrovics G Nat Commun; 2022 Mar; 13(1):1361. PubMed ID: 35292633 [TBL] [Abstract][Full Text] [Related]
17. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450 [TBL] [Abstract][Full Text] [Related]
18. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing. Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082 [TBL] [Abstract][Full Text] [Related]
19. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. Wokołorczyk D; Kluźniak W; Huzarski T; Gronwald J; Szymiczek A; Rusak B; Stempa K; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C; Int J Cancer; 2020 Nov; 147(10):2793-2800. PubMed ID: 32875559 [TBL] [Abstract][Full Text] [Related]
20. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]